医学
微循环
2019年冠状病毒病(COVID-19)
细胞激素风暴
重症监护医学
肺
炎症
冠状病毒
疾病
内科学
传染病(医学专业)
作者
Giovanni Tommaso Ranaldi,Emanuele Rocco Villani,Laura Franza,Giulia Motola
标识
DOI:10.31226/osf.io/c2jvt
摘要
COVID-19 is the respiratory disease caused by the new coronavirus SARS-CoV-2 and is characterized by clinical manifestations ranging from mild, flu-like symptoms, to severe respiratory failure and multi-organ failure. Patients with more severe symptoms may require intensive care treatments and have a high risk of mortality. COVID 19 is characterized by an abnormal inflammatory response similar to a cytokine storm, which is associated with endothelial dysfunction and microvascular complications. To date, no specific treatments are available for COVID-19 and its potentially life-threatening complications.Ozone therapy is the administration of a mixture of ozone and oxygen, or Medical Ozone (MO), which produces a series of benefits capable of counteracting a wide range of pathologies, in use for over a century as an unconventional medicine practice.The use of Ozone therapy with the large auto-hemo-infusion technique could help oxygenate the tissues better, decrease lung inflammation and regulate the immune response, help slow down viral growth, regulate lung circulation and avoid or slow down vascular hypertrophy and consequent hyperemia, especially in the early stages
科研通智能强力驱动
Strongly Powered by AbleSci AI